Diabetes & Obesity
Trusted long-term partner for primary packaging products and drug delivery devices
As the global prevalence of obesity and diabetes increases, so too does the need for therapeutic solutions. To support this growing demand we offer primary packaging and customized delivery devices such as pen injectors that are ideally suited for GLP-1 and insulin.
Facts and figures
About 422 million people worldwide have diabetes
Gerresheimer was one of the first supplier of cartridges for insulins
Worldwide, more than 1 billion people have obesity
Gerresheimer was already a solution supplier for the first-generation GLP-1 products
Type 2 diabetes makes up about 95% of the occurrences of the disease
With over 350 million pens produced per year, Gerresheimer is one of key suppliers of pen injectors
1.5 million deaths are directly attributed to diabetes each year
Diabetes mellitus
Diabetes is a generic term for various metabolic diseases which have in common that they lead to elevated blood glucose levels because patients lack the hormone insulin and/or the insulin effect is reduced. Medically, there are different forms of diabetes, the main forms are type 1 and type 2 diabetes mellitus.
Obesity
Obesity is a medical condition, in which excess body fat has accumulated to such an extent that it may negatively affect health. People are classified as obese when their body mass index (BMI) is over 30 kg/m2.
Excess body fat underlies 64% of cases of type II diabetes in men and 77% of cases in women. Since 2013 obesity is officially classified as a disease.
In the field of diabetes, we cover the entire spectrum of diabetes products
Insulin is a well-known peptide hormone which is produced by the beta cells of the pancreatic islets of the human body. Those hormones promote the development and the maturation of cells in various organs. Insulin is required to take up glucose (sugar) in liver, muscle and fat cells to build energy stores.
For type I diabetes mellitus patients' insulin is key to survive.
Solutions for Insulins
Customized Drug Delivery Devices
Perfect choice for cartridge-based GLP-1. Reusable pen injectors and economically produced disposable pens ensure that active ingredients can be efficiently administered with little pain.
Gx® Advance Cartridges
Available as Bulk and RTF configuration. Baked on siliconization for RTF avoids adsorption on glass surface. Proven device compatibility. Improved fill and finish line performance.
Gx® Advance Vials
Perfect choice for Insulins and GLP-1. Full compliance to all ISO standards with established local-for-local supply chain.
Reliable supplier of integrated drug delivery systems for GLP-1
Incretin mimetics or GLP-1 receptor agonists are a class of antidiabetic agents that were originally developed specifically for the treatment of type 2 diabetes mellitus. They mimic the effect of the body's own hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). Compared to insulin treatment T2D patients can benefit from lower side effects, lower risks of hypoglycemia and increased weight loss.
Solutions for GLP-1
Gx® Advance Syringes & Bypass Syringes
Perfect choice for GLP-1 and GIP. Tight dimension and performance parameters to ensure safe handling within Autoinjectors, reliable siliconization profiles for low BL&GF.
Customized Drug Delivery Devices
Perfect choice for cartridge-based insulins. Reusable pen injectors and economically produced disposable pens ensure that active ingredients can be efficiently administered with little pain.
Gx® Advance Cartridges
Available as Bulk and RTF configuration. Baked on siliconization for RTF avoids adsorption on glass surface. Proven device-compatibility. Improved fill and finish line performance.
Gx® Advance Vials
Perfect choice for Insulins and GLP-1. Full compliance to all ISO standards with established local-for-local supply chain.
Velocity® Vials
Perfect choice for high efficiency on high-speed filling lines. A specific outside coating protects the vials and can improve fill and finish line performance up to 50%.
GLP-1 Obesity Support App
Our GLP-1 obesity support app encourages adherence and sustainable lifestyle changes for your patients and provides you with invaluable real-world data.
Contact the Expert
Dave Long
Global Director Sales & Business Development Syringe Systems
